Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Marla Dubinsky
Icahn School of Medicine at Mount Sinai, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Janssen Biotech
Payment for services (e.g., consulting fees, honoraria, paid authorship)
Dr. Marla Dubinsky (a Co-investigator in this study) receives financial compensation from companies which develop anti-TNF therapies.
Assessing Predictors of Response to Anti-Tumor Necrosis Alpha Therapy in Early Crohns Disease
Anti-tumor necrosis factor alpha inhibitors (anti-TNF) are the most effective medications for Crohn's disease (CD). However, a significant number of patients do not respond to these agents, which are costly and have serious potential side effects. We aim to evaluate peripheral blood and intestinal tissue predictive biomarkers of anti-TNF response in order to develop more personalized medicine approaches for recently diagnosed CD patients.
Filed on May 16, 2019.
Tell us what you know about Marla Dubinsky's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Marla Dubinsky”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Marla Dubinsky | Icahn School of Medicine at Mount Sinai | Conflict of Interest | AbbVie | $20,000 - $39,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.